BBLG
Bone Biologics
BBLG
BBLG
3 hedge funds and large institutions have $67K invested in Bone Biologics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
Holders
3
Holders Change
-1
Holders Change %
-25%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$11K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$9K |
Top Sellers
| 1 |
1
Jane Street
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $47K | 33,461 | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $11K | 7,673 | +7,588 | +8,927% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $9K | 6,165 | +6,165 | New |
|
|
4
Jane Street
New York
| – | – | -13,464 | Closed |
|
|
5
Citadel Advisors
Miami,
Florida
| – | – | -10,741 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|